All Stories

  1. Schistosomiasis‐Associated Pulmonary Arterial Hypertension in Brazil: A Call to Action for Enhanced Diagnostic Recognition—2025 Pulmonary Vascular Research Institute Infection in Pulmonary Vascular Disease Consortium Perspectives
  2. Gas exchange dynamics and responses to exercise in chronic thromboembolic pulmonary hypertension
  3. Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task Force
  4. A Tale of Two Organs: The Liver–Lung Axis in Pulmonary Disease
  5. Chronic Dyspnea and Residual Pulmonary Vascular Sequelae After COVID‐19 Pulmonary Embolism: A Retrospective Analysis
  6. Oxygen pulse plateau as a qualitative marker for risk stratification in PAH
  7. Physiologic relevance of the transpulmonary metabolome in connective tissue disease–associated pulmonary vascular disease
  8. Immune Profile of Peripheral Blood Mononuclear Cells in Patients With Schistosoma-induced Pulmonary Hypertension
  9. Orthostatic hypotension in precapillary pulmonary hypertension: prevalence, clinical profile and hemodynamic mechanisms
  10. Unveiling Orthostatic Hypotension and Its Hemodynamic Mechanisms in Precapillary Pulmonary Hypertension
  11. Morbidity and Mortality Associated With Pulmonary Arterial Hypertension in a Schistosomiasis‐Endemic Region of Brazil
  12. Clinical, Functional, and Hemodynamic Profile of Schistosomiasis-Associated Pulmonary Arterial Hypertension Patients in Brazil: Systematic Review and Meta-Analysis
  13. COVID-19 and Parasitic Co-Infection: A Hypothetical Link to Pulmonary Vascular Disease
  14. Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance
  15. Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling
  16. COVID-19 and Parasitic Coinfection: A Hypothetical Link to Pulmonary Vascular Disease
  17. Prognostic relevance of Exercise Pulmonary Hypertension: Results of the multi-center PEX-NET Clinical Research Collaboration
  18. Infection and pulmonary vascular diseases consortium: United against a global health challenge
  19. The role of the exercise physiology laboratory in disease management: pulmonary arterial hypertension
  20. Cardiopulmonary exercise test 3 to 12 months after COVID-19 hospitalization
  21. Residual lung abnormalities after 12 months of COVID19 hospitalization: A brazilian multicenter study
  22. Dyspnea Investigation in Behçet’s Disease: The Role of Advanced Diagnostic Methods to Elucidate Dyspnea in Systemic Diseases
  23. The role of the pulmonary function laboratory to assist in disease management: pulmonary hypertension
  24. CD147 Plasma Levels in Hospitalised Patients with Covid-19 Pneumonia Predict Illness Severity and In-Hospital Mortality
  25. Pulmonary hypertension outcomes during the COVID-19 pandemic in Brazil
  26. Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
  27. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2
  28. Exercise intolerance in post-coronavirus disease 2019 survivors after hospitalisation
  29. Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges
  30. Exercise metabolomics in pulmonary arterial hypertension: Where pulmonary vascular metabolism meets exercise physiology
  31. Baseline characteristics of patients included into the ERS Clinical Research Collaboration: “Pulmonary Hemodynamics during Exercise - Research Network” (PEX-NET) registry
  32. Mechanisms of exercise intolerance after COVID-19: new perspectives beyond physical deconditioning
  33. Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
  34. Sex-Related Differences in Dynamic Right Ventricular-Pulmonary Vascular Coupling in Heart Failure With Preserved Ejection Fraction
  35. Impact of right ventricular work and pulmonary arterial compliance on peak exercise oxygen uptake in idiopathic pulmonary arterial hypertension
  36. Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
  37. Schistosomiasis Pulmonary Arterial Hypertension
  38. Clinical utility of ventilatory and gas exchange evaluation during low‐intensity exercise for risk stratification and prognostication in pulmonary arterial hypertension
  39. Systemic vascular distensibility relates to exercise capacity in connective tissue disease
  40. Dynamic right ventricular function response to incremental exercise in pulmonary hypertension
  41. Fick principle and exercise pulmonary hemodynamic determinants of the six‐minute walk distance in pulmonary hypertension
  42. Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease
  43. Ventilatory and Gas Exchange Responses During Freewheeling Exercise in Pulmonary Arterial Hypertension
  44. Incremental step test in patients with pulmonary hypertension
  45. EXPRESS: Prognostic value of six-minute walk distance at a South American pulmonary hypertension referral center
  46. Unexplained exertional intolerance associated with impaired systemic oxygen extraction
  47. Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension
  48. Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension
  49. Right Ventricular-Arterial Uncoupling During Exercise in Heart Failure With Preserved Ejection Fraction
  50. Tomographic features associated with excessive ventilatory responses during exercise in chronic pulmonary thromboembolic hypertension
  51. Clinical value of an abnormal increase of O2 pulse during early recovery from maximal exercise in patients with chronic thromboembolic pulmonary hypertension
  52. Dynamic right ventricular-pulmonary arterial (RV-PA) uncoupling during incremental exercise in HFpEF
  53. Right ventriculo–arterial uncoupling and impaired contractile reserve in obese patients with unexplained exercise intolerance
  54. Pulmonary haemodynamics and mortality in chronic hypersensitivity pneumonitis
  55. Pulmonary Vascular Resistance During Exercise Predicts Long-Term Outcomes in Heart Failure With Preserved Ejection Fraction
  56. Network Analysis to Risk Stratify Patients With Exercise IntoleranceNovelty and Significance
  57. Impaired systemic oxygen extraction in treated exercise pulmonary hypertension: a new engine in an old car?
  58. Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
  59. Short and long-term effects of pulmonary endarterectomy on ventilatory responses and exercise capacity of patients with chronic thromboembolic pulmonary hypertension
  60. Prognostic impact of exercise pulmonary hypertension
  61. Functional impact of exercise pulmonary hypertension in patients with borderline pulmonary arterial pressure
  62. Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise
  63. Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure
  64. Hot topics from the Assemblies
  65. Invasive cardiopulmonary exercise testing in the evaluation of unexplained dyspnea: Insights from a multidisciplinary dyspnea center
  66. Development of a Right Ventricular Outflow Tract Gradient During Upright Exercise
  67. Clinical usefulness of end-tidal CO 2 profiles during incremental exercise in patients with chronic thromboembolic pulmonary hypertension
  68. Prognostic role of excessive exercise ventilation in non-operable patients with chronic thromboembolic pulmonary hypertension
  69. Pulmonary haemodynamics during recovery from maximum incremental cycling exercise
  70. PHYSIOLOGIC DYNAMIC RIGHT VENTRICULAR OUTFLOW TRACT OBSTRUCTION DURING EXERCISE: CLINICAL IMPLICATIONS FOR EXERCISE ECHOCARDIOGRAPHY TO IDENTIFY ABNORMAL PULMONARY VASCULAR RESPONSE
  71. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival
  72. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics
  73. Central hemodynamic patterns during recovery from peak exercise
  74. High-dose spironolactone changes renin and aldosterone levels in acutely decompensated heart failure
  75. A haemodynamic study of pulmonary hypertension in chronic hypersensitivity pneumonitis
  76. Erratum
  77. Usefulness of pulmonary capillary wedge pressure as a correlate of left ventricular filling pressures in pulmonary arterial hypertension
  78. Destaques das diretrizes de doenças pulmonares intersticiais da Sociedade Brasileira de Pneumologia e Tisiologia